CS logo
small CS logo
CHU Angers-Service d'Hepato-Gastroenterologie

Angers, France
Centre hospitalier universitaire

About CHU Angers-Service d'Hepato-Gastroenterologie


Le Centre hospitalier universitaire d'Angers est un centre hospitalier universitaire français qui emploie près de 6 700 personnels hospitaliers dont plus de 1 200 personnels médicaux et pharmaceutiques.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at CHU Angers-Service d'Hepato-Gastroenterologie


During the past decade, CHU Angers-Service d'Hepato-Gastroenterologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Angers-Service d'Hepato-Gastroenterologie" #1 collaborator was "Sanofi" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at CHU Angers-Service d'Hepato-Gastroenterologie


According to Clinical.Site data, the most researched conditions in "CHU Angers-Service d'Hepato-Gastroenterologie" are "Hepatitis C, Chronic" (1 trials) and "Non Alcoholic Steatohepatitis (NASH)" (1 trials). Many other conditions were trialed in "CHU Angers-Service d'Hepato-Gastroenterologie" in a lesser frequency.

Clinical Trials Intervention Types at CHU Angers-Service d'Hepato-Gastroenterologie


Most popular intervention types in "CHU Angers-Service d'Hepato-Gastroenterologie" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Irbesartan" (1 trials), "Obeticholic Acid" (1 trials), "Placebo" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at CHU Angers-Service d'Hepato-Gastroenterologie


The vast majority of trials in "CHU Angers-Service d'Hepato-Gastroenterologie" are 2 trials for "All" genders.

Clinical Trials Status at CHU Angers-Service d'Hepato-Gastroenterologie


Currently, there are NaN active trials in "CHU Angers-Service d'Hepato-Gastroenterologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CHU Angers-Service d'Hepato-Gastroenterologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CHU Angers-Service d'Hepato-Gastroenterologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".